Abstract
Septic shock is a life-threatening condition characterized by profound circulatory dysfunction and persistent hypotension, requiring rapid hemodynamic stabilization. The objective of this study was to compare the effectiveness of early norepinephrine administration with standard treatment in achieving shock control among patients with septic shock. A randomized controlled trial was conducted in the Department of Medicine, Provincial Headquarter Hospital, Gilgit, from May 2026 to August 2026. A total of 106 patients aged 18–65 years with septic shock were enrolled through non-probability consecutive sampling and randomly allocated equally to an early norepinephrine group and a standard-treatment group, with 53 patients in each group. Both groups received standard septic shock management, including crystalloid resuscitation, antibiotics, source control, and organ support. The mean age was 49.1 ± 11.8 years in the early norepinephrine group and 50.4 ± 12.2 years in the standard-treatment group (p = 0.578). Baseline mean arterial pressure was also comparable between the groups (56.7 ± 5.8 vs. 57.4 ± 6.1 mmHg; p = 0.546). Shock control was achieved in 40 (75.5%) patients receiving early norepinephrine compared with 26 (49.1%) patients receiving standard treatment (χ2 = 7.88, p = 0.005). Mean arterial pressure at 1 hour was significantly higher in the early norepinephrine group (68.9 ± 7.0 vs. 63.2 ± 7.6 mmHg; p < 0.001), with significant differences persisting at 6 hours (73.8 ± 6.6 vs. 68.5 ± 7.4 mmHg; p < 0.001) and 24 hours (76.1 ± 7.1 vs. 71.9 ± 7.8 mmHg; p = 0.005). These findings indicate that early norepinephrine administration was more effective than standard treatment in achieving shock control and produced a more rapid improvement in mean arterial pressure among patients with septic shock.
Keywords: septic shock, norepinephrine, vasopressor, shock control, mean arterial pressure, hemodynamic stabilization
Abstract
Septic shock is a life-threatening condition characterized by profound circulatory dysfunction and persistent hypotension, requiring rapid hemodynamic stabilization. The objective of this study was to compare the effectiveness of early norepinephrine administration with standard treatment in achieving shock control among patients with septic shock. A randomized controlled trial was conducted in the Department of Medicine, Provincial Headquarter Hospital, Gilgit, from May 2026 to August 2026. A total of 106 patients aged 18–65 years with septic shock were enrolled through non-probability consecutive sampling and randomly allocated equally to an early norepinephrine group and a standard-treatment group, with 53 patients in each group. Both groups received standard septic shock management, including crystalloid resuscitation, antibiotics, source control, and organ support. The mean age was 49.1 ± 11.8 years in the early norepinephrine group and 50.4 ± 12.2 years in the standard-treatment group (p = 0.578). Baseline mean arterial pressure was also comparable between the groups (56.7 ± 5.8 vs. 57.4 ± 6.1 mmHg; p = 0.546). Shock control was achieved in 40 (75.5%) patients receiving early norepinephrine compared with 26 (49.1%) patients receiving standard treatment (χ2 = 7.88, p = 0.005). Mean arterial pressure at 1 hour was significantly higher in the early norepinephrine group (68.9 ± 7.0 vs. 63.2 ± 7.6 mmHg; p < 0.001), with significant differences persisting at 6 hours (73.8 ± 6.6 vs. 68.5 ± 7.4 mmHg; p < 0.001) and 24 hours (76.1 ± 7.1 vs. 71.9 ± 7.8 mmHg; p = 0.005). These findings indicate that early norepinephrine administration was more effective than standard treatment in achieving shock control and produced a more rapid improvement in mean arterial pressure among patients with septic shock.
Keywords: septic shock, norepinephrine, vasopressor, shock control, mean arterial pressure, hemodynamic stabilization
References
- Suh, Gil Joon, et al. “Hemodynamic Management of Septic Shock: Beyond
the Surviving Sepsis Campaign Guidelines.” Clinical and Experimental
Emergency Medicine, vol. 10, no. 3, 2023, pp. 255–264.
- Shi, Rui, Olfa Hamzaoui, Nello De Vita, Xavier Monnet, and Jean-Louis
Teboul. “Vasopressors in Septic Shock: Which, When, and How Much?”
Annals of Translational Medicine, vol. 8, no. 12, 2020, article
794.
- Bughrara, Nibras, Stephanie Cha, Radwan Safa, and Aliaksei
Pustavoitau. “Perioperative Management of Patients with Sepsis and
Septic Shock, Part I: Systematic Approach.” Anesthesiology
Clinics, vol. 38, no. 1, 2020, pp. 107–122.
- Xiang, Hui, et al. “Dose-Related Effects of Norepinephrine on
Early-Stage Endotoxemic Shock in a Swine Model.” Journal of
Intensive Medicine, vol. 3, no. 4, 2023, pp. 335–344.
- Gelman, Simon. “Norepinephrine Produces Two Different Haemodynamic
Effects Depending on the Dose Used.” European Journal of
Anaesthesiology, vol. 41, no. 3, 2024, pp. 157–160.
- Feldheiser, Aarne, Simon Gelman, Michelle Chew, and Matthias
Stopfkuchen-Evans. “Vasopressor Effects on Venous Return in Septic
Patients: A Review.” European Journal of Anaesthesiology, vol.
38, no. 6, 2021, pp. 659–663.
- Persichini, Romain, et al. “Venous Return and Mean Systemic Filling
Pressure: Physiology and Clinical Applications.” Critical Care,
vol. 26, no. 1, 2022, article 150.
- Permpikul, Chairat, et al. “Early Use of Norepinephrine in Septic
Shock Resuscitation (CENSER). A Randomized Trial.” American Journal
of Respiratory and Critical Care Medicine, vol. 199, no. 9, 2019,
pp. 1097–1105.
- Bai, Xiaowu, et al. “Early versus Delayed Administration of
Norepinephrine in Patients with Septic Shock.” Critical Care,
vol. 18, no. 5, 2014, article 532.
- Elbouhy, Mohamed A., Mohamed Soliman, Aymen Gaber, Khaled M. Taema,
and Ahmed Abdel-Aziz. “Early Use of Norepinephrine Improves Survival in
Septic Shock: Earlier than Early.” Archives of Medical
Research, vol. 50, no. 6, 2019, pp. 325–332.
- Ospina-Tascón, Gustavo A., et al. “Effects of Very Early Start of
Norepinephrine in Patients with Septic Shock: A Propensity Score-Based
Analysis.” Critical Care, vol. 24, no. 1, 2020, article 52.
- Xu, Fei, Rong Zhong, Shanyang Shi, Yiqian Zeng, and Zhanhong Tang.
“Early Initiation of Norepinephrine in Patients with Septic Shock: A
Propensity Score-Based Analysis.” The American Journal of Emergency
Medicine, vol. 54, 2022, pp. 287–296.
- Abe, Toshikazu, et al. “Early versus Delayed Vasopressor
Administration in Patients with Septic Shock.” Acute Medicine &
Surgery, vol. 10, no. 1, 2023, article e852.
- Maheshwari, Kamal, et al. “The Relationship between ICU Hypotension
and In-Hospital Mortality and Morbidity in Septic Patients.”
Intensive Care Medicine, vol. 44, no. 6, 2018, pp. 857–867.
- Hamzaoui, Olfa, et al. “Norepinephrine Exerts an Inotropic Effect
during the Early Phase of Human Septic Shock.” British Journal of
Anaesthesia, vol. 120, no. 3, 2018, pp. 517–524.
- Patel, Gourang P., et al. “Efficacy and Safety of Dopamine versus
Norepinephrine in the Management of Septic Shock.” Shock, vol.
33, no. 4, 2010, pp. 375–380.
- Russell, James A., et al. “Vasopressin versus Norepinephrine Infusion
in Patients with Septic Shock.” The New England Journal of
Medicine, vol. 358, no. 9, 2008, pp. 877–887.
- Delaney, Anthony, et al. “Initiation of Vasopressor Infusions via
Peripheral versus Central Access in Patients with Early Septic Shock: A
Retrospective Cohort Study.” Emergency Medicine Australasia,
vol. 32, no. 2, 2020, pp. 210–219.
How to cite:
Nida Zahra, Fazil Hussain, Ali Mehdi, Reena Wafa, Muhammad Saqlain, Asiya. Comparison of Early Norepinephrine Administration Versus Standard Treatment in Patients With Septic Shock. Revista Cultura Científica, 2026 Issue 24. pg. 1658-1666.
Publication History
-
Received: 07/08/2026
-
Accepted: 01/10/2026
-
Published: 07/10/2026
Copyright © 2026, Nida Zahra, Fazil Hussain, Ali Mehdi, Reena Wafa, Muhammad Saqlain, Asiya. Published by Revista Cultura Científica. This article is published as open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) license (
http://creativecommons.org/licenses/by/4.0/).